Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$77.92
0.0%
$89.86
$51.79
$101.40
$10.55B11.27 million shs540,837 shs
Insulet Corporation stock logo
PODD
Insulet
$154.23
+0.0%
$211.22
$148.30
$354.88
$10.67B1.21.10 million shs289,051 shs
STERIS plc stock logo
STE
STERIS
$203.20
-2.1%
$224.30
$195.14
$269.44
$19.93B0.95764,251 shs218,142 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$130.15
-2.2%
$119.44
$100.18
$139.67
$5.76B0.82961,824 shs212,164 shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.00%-14.76%-14.03%-11.18%+40.10%
Insulet Corporation stock logo
PODD
Insulet
0.00%-11.93%-21.72%-37.22%-50.34%
STERIS plc stock logo
STE
STERIS
0.00%-3.44%-6.76%-15.48%-8.45%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%+9.12%+12.49%+25.31%+6.45%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$77.92
0.0%
$89.86
$51.79
$101.40
$10.55B11.27 million shs540,837 shs
Insulet Corporation stock logo
PODD
Insulet
$154.23
+0.0%
$211.22
$148.30
$354.88
$10.67B1.21.10 million shs289,051 shs
STERIS plc stock logo
STE
STERIS
$203.20
-2.1%
$224.30
$195.14
$269.44
$19.93B0.95764,251 shs218,142 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$130.15
-2.2%
$119.44
$100.18
$139.67
$5.76B0.82961,824 shs212,164 shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.00%-14.76%-14.03%-11.18%+40.10%
Insulet Corporation stock logo
PODD
Insulet
0.00%-11.93%-21.72%-37.22%-50.34%
STERIS plc stock logo
STE
STERIS
0.00%-3.44%-6.76%-15.48%-8.45%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%+9.12%+12.49%+25.31%+6.45%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.81
Moderate Buy$106.3636.50% Upside
Insulet Corporation stock logo
PODD
Insulet
2.71
Moderate Buy$257.0966.69% Upside
STERIS plc stock logo
STE
STERIS
2.71
Moderate Buy$275.2035.44% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.22
Hold$142.869.76% Upside

Current Analyst Ratings Breakdown

Latest TFX, STE, GMED, and PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Teleflex Incorporated stock logo
TFX
Teleflex
Reiterated RatingOutperform$150.00
5/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetOverweight$104.00 ➝ $103.00
5/8/2026
Teleflex Incorporated stock logo
TFX
Teleflex
Set Price Target$140.00
5/8/2026
Teleflex Incorporated stock logo
TFX
Teleflex
UpgradeSector PerformOutperform$135.00 ➝ $155.00
5/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Boost Price TargetOutperform$115.00 ➝ $120.00
5/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Boost Price TargetBuy$114.00 ➝ $117.00
5/8/2026
Teleflex Incorporated stock logo
TFX
Teleflex
Boost Price TargetEqual Weight$130.00 ➝ $138.00
5/7/2026
Insulet Corporation stock logo
PODD
Insulet
Set Price Target$237.00
5/7/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetOutperform$325.00 ➝ $280.00
5/7/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetBuy$315.00 ➝ $250.00
5/7/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetOutperform$330.00 ➝ $200.00
(Data available from 5/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$3.10B3.40$6.28 per share12.41$33.86 per share2.30
Insulet Corporation stock logo
PODD
Insulet
$2.71B3.94$6.33 per share24.38$21.54 per share7.16
STERIS plc stock logo
STE
STERIS
$5.46B3.65$13.97 per share14.55$67.33 per share3.02
Teleflex Incorporated stock logo
TFX
Teleflex
$1.99B2.89$10.95 per share11.89$70.71 per share1.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$4.3018.1415.431.7118.92%13.46%11.65%N/A
Insulet Corporation stock logo
PODD
Insulet
$247.10M$4.3035.8419.261.2510.44%26.87%12.01%N/A
STERIS plc stock logo
STE
STERIS
$614.64M$7.1728.3418.41N/A12.15%14.34%9.58%5/11/2026 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
-$905.64M-$22.80N/A13.000.96-35.88%13.29%6.55%7/30/2026 (Estimated)

Latest TFX, STE, GMED, and PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q4 2026
STERIS plc stock logo
STE
STERIS
$2.86N/AN/AN/A$1.59 billionN/A
5/7/2026Q1 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.92$1.12+$0.20$0.90$740.35 million$759.85 million
5/7/2026Q1 2026
Teleflex Incorporated stock logo
TFX
Teleflex
$1.21$1.39+$0.18-$0.18$536.91 million$548.30 million
5/6/2026Q1 2026
Insulet Corporation stock logo
PODD
Insulet
$1.19$1.42+$0.23$1.30$729.89 million$761.70 million
2/26/2026Q4 2025
Teleflex Incorporated stock logo
TFX
Teleflex
$3.73$1.93-$1.80-$16.15$912.57 million$569.00 million
2/24/2026Q4 2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.06$1.28+$0.22$1.03$803.29 million$826.42 million
2/18/2026Q4 2025
Insulet Corporation stock logo
PODD
Insulet
$1.48$1.55+$0.07$1.44$768.31 million$783.80 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
STERIS plc stock logo
STE
STERIS
$2.521.24%+8.99%35.15%20 Years
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.04%N/AN/A N/A

Latest TFX, STE, GMED, and PODD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2026
STERIS plc stock logo
STE
STERIS
quarterly$0.631.18%6/8/20266/8/20266/26/2026
2/24/2026
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.2%3/6/20263/6/20263/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.56
2.95
Insulet Corporation stock logo
PODD
Insulet
0.71
2.49
1.81
STERIS plc stock logo
STE
STERIS
0.26
2.48
1.75
Teleflex Incorporated stock logo
TFX
Teleflex
0.82
2.55
2.03

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Insulet Corporation stock logo
PODD
Insulet
N/A
STERIS plc stock logo
STE
STERIS
94.69%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
Insulet Corporation stock logo
PODD
Insulet
0.36%
STERIS plc stock logo
STE
STERIS
1.07%
Teleflex Incorporated stock logo
TFX
Teleflex
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000135.25 million110.39 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
5,40069.26 million69.02 millionOptionable
STERIS plc stock logo
STE
STERIS
17,78798.07 million97.03 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
15,50044.26 million43.96 millionOptionable

Recent News About These Companies

Why Is Teleflex Stock Trending Right Now
RBC Capital upgrades Teleflex (TFX)
Teleflex: Q1 Earnings Snapshot
Teleflex (TFX) Q1 2026 Earnings Transcript
Teleflex (NYSE:TFX) Beats Q1 CY2026 Sales Expectations

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Globus Medical stock logo

Globus Medical NYSE:GMED

$77.92 -0.03 (-0.04%)
As of 11:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Insulet stock logo

Insulet NASDAQ:PODD

$154.23 +0.07 (+0.05%)
As of 11:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

STERIS stock logo

STERIS NYSE:STE

$203.20 -4.26 (-2.05%)
As of 11:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Teleflex stock logo

Teleflex NYSE:TFX

$130.15 -2.91 (-2.19%)
As of 11:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.